BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005;32:140-63. [PMID: 15825186 DOI: 10.1002/mus.20304] [Cited by in Crossref: 268] [Cited by in F6Publishing: 282] [Article Influence: 14.9] [Reference Citation Analysis]
Number Citing Articles
1 Brunker LB, Boncyk CS, Rengel KF, Hughes CG. Elderly Patients and Management in Intensive Care Units (ICU): Clinical Challenges. CIA 2023;Volume 18:93-112. [DOI: 10.2147/cia.s365968] [Reference Citation Analysis]
2 Gobbi M, Brunani A, Arreghini M, Baccalaro G, Dellepiane D, La Vela V, Lucchetti E, Barbaglia M, Cova A, Fornara E, Galli S, Cimolin V, Brugliera L, Capodaglio P. Nutritional status in post SARS-Cov2 rehabilitation patients. Clin Nutr 2022;41:3055-60. [PMID: 34049750 DOI: 10.1016/j.clnu.2021.04.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
3 Savevska CG, Radovikj MG, Gechevska D, Koevska V, Mitrevska B, Gocevska M, Matjanoska LS, Ivanovsk BK, Manoleva M. Management of Polyneuromyopathy in a Critically Ill Patient with a Left Ventricular Assist Device. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2022;43:67-72. [PMID: 36473039 DOI: 10.2478/prilozi-2022-0038] [Reference Citation Analysis]
4 Yang Z, Wang X, Wang F, Peng Z, Fan Y. A systematic review and meta-analysis of risk factors for intensive care unit acquired weakness. Medicine (Baltimore) 2022;101:e31405. [PMID: 36316900 DOI: 10.1097/MD.0000000000031405] [Reference Citation Analysis]
5 Ji Y, Li M, Chang M, Liu R, Qiu J, Wang K, Deng C, Shen Y, Zhu J, Wang W, Xu L, Sun H. Inflammation: Roles in Skeletal Muscle Atrophy. Antioxidants 2022;11:1686. [DOI: 10.3390/antiox11091686] [Reference Citation Analysis]
6 Zhang Y, Huang C, Lu W, Hu Q. Case Report: Delayed Guillain-Barré syndrome following trauma: A case series and manage considerations. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.903334] [Reference Citation Analysis]
7 Sekhniashvili M, Bodechtel U, Toyka KV, Baum P. Temporary reversal of nerve and muscle dysfunction by serial electrical stimulation in critical illness neuromyopathy. Clinical Neurophysiology 2022. [DOI: 10.1016/j.clinph.2022.07.509] [Reference Citation Analysis]
8 Isfort M, McVerry BJ, Shutter L, Kim M, Lacomis D. Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers. Muscle Nerve 2022;66:90-5. [PMID: 35470438 DOI: 10.1002/mus.27561] [Reference Citation Analysis]
9 Silva CC, Bichara CNC, Carneiro FRO, Palacios VRDCM, Berg AVSVD, Quaresma JAS, Magno Falcão LF. Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach. Rev Med Virol 2022;:e2355. [PMID: 35416359 DOI: 10.1002/rmv.2355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Skibska B, Skibska A, Gorąca A. The effect of lipoic acid on the content of SOD-1 and TNF-α in rat striated muscle. Postępy Higieny i Medycyny Doświadczalnej 2022;76:11-5. [DOI: 10.2478/ahem-2021-0051] [Reference Citation Analysis]
11 Rudolph MW, Slager S, Burgerhof JGM, van Woensel JB, Alffenaar JC, Wösten - van Asperen RM, de Hoog M, Ijland MM, Kneyber MCJ; For the SKIC research consortium. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome. Trials 2022;23. [DOI: 10.1186/s13063-021-05927-w] [Reference Citation Analysis]
12 Tortuyaux R, Davion JB, Jourdain M. Intensive care unit-acquired weakness: Questions the clinician should ask. Rev Neurol (Paris) 2022:S0035-3787(21)00793-1. [PMID: 34998522 DOI: 10.1016/j.neurol.2021.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ruck T, Hartung H, Meuth SG, Kieseier BC, Lehmann HC. Neuromuskuläre Erkrankungen bei Intensivpatienten. Die Intensivmedizin 2022. [DOI: 10.1007/978-3-642-54675-4_59-2] [Reference Citation Analysis]
14 Horn J, Latronico N. ICU-Related Neuromuscular Weakness and Neuromuscular Differential Diagnoses in the ICU. Emergencies in Neuromuscular Disorders 2022. [DOI: 10.1007/978-3-030-91932-0_14] [Reference Citation Analysis]
15 Palakshappa JA, Krall JTW, Belfield LT, Files DC. Long-Term Outcomes in Acute Respiratory Distress Syndrome: Epidemiology, Mechanisms, and Patient Evaluation. Crit Care Clin 2021;37:895-911. [PMID: 34548140 DOI: 10.1016/j.ccc.2021.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Cao YY, Wang Z, Yu T, Zhang Y, Wang ZH, Lu ZM, Lu WH, Yu JB. Sepsis induces muscle atrophy by inhibiting proliferation and promoting apoptosis via PLK1-AKT signalling. J Cell Mol Med 2021;25:9724-39. [PMID: 34514712 DOI: 10.1111/jcmm.16921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Hokkoku K, Erra C, Cuccagna C, Coraci D, Gatto DM, Glorioso D, Padua L. Intensive Care Unit-Acquired Weakness and Positioning-Related Peripheral Nerve Injuries in COVID-19: A Case Series of Three Patients and the Latest Literature Review. Brain Sci 2021;11:1177. [PMID: 34573198 DOI: 10.3390/brainsci11091177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Stoian A, Bajko Z, Maier S, Cioflinc RA, Grigorescu BL, Moțățăianu A, Bărcuțean L, Balașa R, Stoian M. High-dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS-CoV-2 infection: A case-based review of the literature (Review). Exp Ther Med 2021;22:1182. [PMID: 34475972 DOI: 10.3892/etm.2021.10616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Oikonomou E, Paraskevas T, Velissaris D. Sepsis and the muscle tissue. A narrative review. Rom J Intern Med 2021;59:218-26. [PMID: 33544555 DOI: 10.2478/rjim-2021-0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Kim DY. The Pathologic Mechanisms and Epidemiology of Dysphagia Associated with COVID-19. Journal of the Korean Dysphagia Society 2021;11:87-92. [DOI: 10.34160/jkds.2021.11.2.001] [Reference Citation Analysis]
21 Pro S, Vinti L, Boni A, Mastronuzzi A, Scilipoti M, Velardi M, Caroleo AM, Farina E, Badolato F, Alessi I, Di Nardo G, Carai A, Valeriani M, Reale A, Parisi P, Raucci U. Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies. J Clin Med 2021;10:3016. [PMID: 34300182 DOI: 10.3390/jcm10143016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Baykal D, Çavuşoğlu A, Öztürk Erden S. Hasta Ailesinin, Nöroloji Yoğun Bakım Hemşireleriyle İletişiminin Araştırılması. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi 2021. [DOI: 10.38079/igusabder.870481] [Reference Citation Analysis]
23 Frithiof R, Rostami E, Kumlien E, Virhammar J, Fällmar D, Hultström M, Lipcsey M, Ashton N, Blennow K, Zetterberg H, Punga AR. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin Neurophysiol 2021;132:1733-40. [PMID: 33875374 DOI: 10.1016/j.clinph.2021.03.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 27.5] [Reference Citation Analysis]
24 Bax F, Lettieri C, Marini A, Pellitteri G, Surcinelli A, Valente M, Budai R, Patruno V, Gigli GL. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19. Neurol Sci 2021;42:2173-8. [PMID: 33755815 DOI: 10.1007/s10072-021-05110-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
25 Cheung K, Rathbone A, Melanson M, Trier J, Ritsma BR, Allen MD. Pathophysiology and management of critical illness polyneuropathy and myopathy. J Appl Physiol (1985) 2021;130:1479-89. [PMID: 33734888 DOI: 10.1152/japplphysiol.00019.2021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
26 Wang J, Wu T. Testosterone improves muscle function of the extensor digitorum longus in rats with sepsis. Biosci Rep 2020;40:BSR20193342. [PMID: 31967292 DOI: 10.1042/BSR20193342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Luo J, Xia Z, Che Y, Zhou K. Characteristics, treatments, and prognosis of a critical illness polyneuromyopathy patient with positive anti-GM1 after severe traumatic brain injury: A case report. Clin Exp Pharmacol Physiol 2021;48:831-6. [PMID: 33715175 DOI: 10.1111/1440-1681.13496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Tankisi A, Pedersen TH, Bostock H, Z'Graggen WJ, Larsen LH, Meldgaard M, Elkmann T, Tankisi H. Early detection of evolving critical illness myopathy with muscle velocity recovery cycles. Clin Neurophysiol 2021;132:1347-57. [PMID: 33676846 DOI: 10.1016/j.clinph.2021.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
29 Souron R, Morel J, Gergelé L, Infantino P, Brownstein CG, Lapole T, Millet GY. Relationship between intensive care unit-acquired weakness, fatigability and fatigue: What role for the central nervous system? J Crit Care 2021;62:101-10. [PMID: 33316555 DOI: 10.1016/j.jcrc.2020.11.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wang W, Xu C, Ma X, Zhang X, Xie P. Intensive Care Unit-Acquired Weakness: A Review of Recent Progress With a Look Toward the Future. Front Med (Lausanne) 2020;7:559789. [PMID: 33330523 DOI: 10.3389/fmed.2020.559789] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
31 Park S, Jeong Y, Kim N. Critical illness neuromyopathy. ACN 2020;22:61-66. [DOI: 10.14253/acn.2020.22.2.61] [Reference Citation Analysis]
32 Rakhimov RT, Leyderman IN, Belkin AA. Respiratory Neuropathy as an Important Component of Critical Illness Polyneuromyopathy. Neotložnaâ med pomoŝʹ 2020;9:108-122. [DOI: 10.23934/2223-9022-2020-9-1-108-122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Z'Graggen WJ, Tankisi H. Critical Illness Myopathy. J Clin Neurophysiol 2020;37:200-4. [PMID: 32358245 DOI: 10.1097/WNP.0000000000000652] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
34 Solmaz V, Kaya M, Uslu FB, Atasoy O, Erbaş O. Papaverine Has Therapeutic Potential for Sepsis-Induced Neuropathy in Rats, Possibly via the Modulation of HMGB1-RAGE Axis and Its Antioxidant Prosperities. J Invest Surg 2020;:1-7. [PMID: 32842806 DOI: 10.1080/08941939.2020.1809751] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 D'Souza A, Simo R, D'Souza A, Vaz F, Prior A, Kanegaonkar R. Tracheostomy intervention in intubated COVID positive patients: A survey of current clinical practice among ENT surgeons. Head Neck 2020;42:1382-5. [PMID: 32501600 DOI: 10.1002/hed.26274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
36 Carda S, Invernizzi M, Bavikatte G, Bensmaïl D, Bianchi F, Deltombe T, Draulans N, Esquenazi A, Francisco GE, Gross R, Jacinto LJ, Moraleda Pérez S, O'dell MW, Reebye R, Verduzco-Gutierrez M, Wissel J, Molteni F. COVID-19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician's perspective. Eur J Phys Rehabil Med 2020;56:515-24. [PMID: 32434314 DOI: 10.23736/S1973-9087.20.06317-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 60] [Article Influence: 14.0] [Reference Citation Analysis]
37 Mart MF, Ware LB. The long-lasting effects of the acute respiratory distress syndrome. Expert Rev Respir Med 2020;14:577-86. [PMID: 32168460 DOI: 10.1080/17476348.2020.1743182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
38 Mahashabde M, Chaudhary G, Kanchi G, Rohatgi S, Rao P, Patil R, Nallamothu V. An Unusual Case of Critical Illness Polyneuromyopathy. Indian J Crit Care Med 2020;24:133-5. [PMID: 32205946 DOI: 10.5005/jp-journals-10071-23346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Latronico N, Hermans G. Critical Illness Neuromyopathy: Clinical, Electrophysiological, and Histological Diagnosis. Lessons from the ICU 2020. [DOI: 10.1007/978-3-030-24250-3_4] [Reference Citation Analysis]
40 Mars T, Mis K, Katalinic M, Pegan K, Grubic Z, Pirkmajer S. The effects of organophosphates in the early stages of human skeletal muscle regeneration. Handbook of Toxicology of Chemical Warfare Agents 2020. [DOI: 10.1016/b978-0-12-819090-6.00049-0] [Reference Citation Analysis]
41 Brunkhorst F, Axer H. What are the causes of and how do I treat critical illness neuropathy/myopathy? Evidence-Based Practice of Critical Care 2020. [DOI: 10.1016/b978-0-323-64068-8.00038-9] [Reference Citation Analysis]
42 Chandrasekaran PN, Pandey A, Idiculla PS. Neuromuscular Emergencies in the Neuroscience Intensive Care Unit. Neuromuscular Urgencies and Emergencies 2020. [DOI: 10.1007/978-3-030-53145-4_5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
43 Hlophe ST, Masekela R. Life after paediatric intensive care unit. Afr J Thorac Crit Care Med 2019;25. [PMID: 34286263 DOI: 10.7196/AJTCCM.2019.v25i4.027] [Reference Citation Analysis]
44 Schmidt D, Coelho AC, Vieira FN, Torres VF, Savi A, Vieira SRR. Critical illness polyneuromyopathy in septic patients: Is it possible to diagnose it in a bedside clinical examination? Arq Neuropsiquiatr 2019;77:33-8. [PMID: 30758440 DOI: 10.1590/0004-282X20180144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Wang J, Wu T. Testosterone improves muscle function of the extensor digitorum longus in rats with sepsis.. [DOI: 10.1101/850636] [Reference Citation Analysis]
46 Pennisi M, Malaguarnera G, Di Bartolo G, Lanza G, Bella R, Chisari EM, Cauli O, Vicari E, Malaguarnera M. Decrease in Serum Vitamin D Level of Older Patients with Fatigue. Nutrients 2019;11:E2531. [PMID: 31635199 DOI: 10.3390/nu11102531] [Reference Citation Analysis]
47 Pennisi M, Malaguarnera G, Di Bartolo G, Lanza G, Bella R, Chisari EM, Cauli O, Vicari E, Malaguarnera M. Decrease in Serum Vitamin D Level of Older Patients with Fatigue. Nutrients 2019;11:E2531. [PMID: 31635199 DOI: 10.3390/nu11102531] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
48 Mobach T, Brooks J, Breiner A, Warman-Chardon J, Papp S, Gammon B, Nandedkar SD, Bourque PR. Impact of disuse muscular atrophy on the compound muscle action potential. Muscle Nerve 2020;61:58-62. [PMID: 31588576 DOI: 10.1002/mus.26730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Kramer CL, Manno EM, Rabinstein AA. Neuromuscular Disorders in the Neurocritical Care Unit. Neurocritical Care 2019. [DOI: 10.1017/9781107587908.016] [Reference Citation Analysis]
50 García-Martínez MÁ, Montejo González JC, García-de-Lorenzo Y Mateos A, Teijeira S. Muscle weakness: Understanding the principles of myopathy and neuropathy in the critically ill patient and the management options. Clin Nutr 2020;39:1331-44. [PMID: 31255348 DOI: 10.1016/j.clnu.2019.05.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 C. Synopsis of Neurology, Psychiatry and Related Systemic Disorders 2019. [DOI: 10.1017/9781107706866.003] [Reference Citation Analysis]
52 Shible AA, Ramadurai D, Gergen D, Reynolds PM. Dry Beriberi Due to Thiamine Deficiency Associated with Peripheral Neuropathy and Wernicke's Encephalopathy Mimicking Guillain-Barré syndrome: A Case Report and Review of the Literature. Am J Case Rep 2019;20:330-4. [PMID: 30862772 DOI: 10.12659/AJCR.914051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
53 Abad S, Bonnet N, Bouvry D, Cohen Y, Dhote R. [Rhabdomyolysis in patients treated by corticosteroids for acute asthma in intensive care unit]. Rev Med Interne 2019;40:255-7. [PMID: 30616928 DOI: 10.1016/j.revmed.2018.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Babi M. Neuromuscular Weakness in the ICU. Textbook of Neuroanesthesia and Neurocritical Care 2019. [DOI: 10.1007/978-981-13-3390-3_6] [Reference Citation Analysis]
55 Hannawi Y, Shah JN, Haji S, Mirski MA. Critical Care Neurology. Atlas of Clinical Neurology 2019. [DOI: 10.1007/978-3-030-03283-8_4] [Reference Citation Analysis]
56 Rajagopalan S, Baghshomali S, Navarro JC, Kalanuria AA. Intensive Care Management of the Neuromuscular Patient. Textbook of Neuroanesthesia and Neurocritical Care 2019. [DOI: 10.1007/978-981-13-3390-3_5] [Reference Citation Analysis]
57 Yu X, Han W, Wang C, Sui D, Bian J, Bo L, Deng X. Upregulation of Heme Oxygenase-1 by Hemin Alleviates Sepsis-Induced Muscle Wasting in Mice. Oxid Med Cell Longev 2018;2018:8927104. [PMID: 30533176 DOI: 10.1155/2018/8927104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
58 Schreiber A, Bertoni M, Goligher EC. Avoiding Respiratory and Peripheral Muscle Injury During Mechanical Ventilation: Diaphragm-Protective Ventilation and Early Mobilization. Crit Care Clin 2018;34:357-81. [PMID: 29907270 DOI: 10.1016/j.ccc.2018.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
59 Kramer CL. Intensive Care Unit-Acquired Weakness. Neurol Clin. 2017;35:723-736. [PMID: 28962810 DOI: 10.1016/j.ncl.2017.06.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
60 Baek WK, Kim YS, Kim JT, Yoon B. Critical Illness Neuromyopathy Complicating Cardiac Surgery. Acute Crit Care 2018;33:51-56. [DOI: 10.4266/kjccm.2016.00255] [Reference Citation Analysis]
61 Katzberg HD, Kassardjian CD. Toxic and Endocrine Myopathies. Continuum (Minneap Minn) 2016;22:1815-28. [PMID: 27922495 DOI: 10.1212/CON.0000000000000407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
62 Ferentzi H, Pfitzer C, Rosenthal LM, Berger F, Schmitt KRL. Long-term early development research in congenital heart disease (LEADER-CHD): a study protocol for a prospective cohort observational study investigating the development of children after surgical correction for congenital heart defects during the first 3 years of life. BMJ Open 2017;7:e018966. [PMID: 29288186 DOI: 10.1136/bmjopen-2017-018966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Roberson AR, Starkweather A, Grossman C, Acevedo E, Salyer J. Influence of muscle strength on early mobility in critically ill adult patients: Systematic literature review. Heart Lung 2018;47:1-9. [PMID: 29217105 DOI: 10.1016/j.hrtlng.2017.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Ojha A, Zivkovic SA, Lacomis D. Electrodiagnostic studies in the intensive care unit: A comparison study 2 decades later. Muscle Nerve 2018;57:772-6. [PMID: 29053882 DOI: 10.1002/mus.25998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
65 Silva PE, Maldaner V, Vieira L, de Carvalho KL, Gomes H, Melo P, Babault N, Cipriano G Jr, Durigan JLQ. Neuromuscular electrophysiological disorders and muscle atrophy in mechanically-ventilated traumatic brain injury patients: New insights from a prospective observational study. J Crit Care 2018;44:87-94. [PMID: 29078131 DOI: 10.1016/j.jcrc.2017.10.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
66 Senger D, Erbguth F. [Critical illness myopathy and polyneuropathy]. Med Klin Intensivmed Notfmed 2017;112:589-96. [PMID: 28875277 DOI: 10.1007/s00063-017-0339-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
67 Nayak R. Practical approach to the patient with acute neuromuscular weakness. World J Clin Cases 2017; 5(7): 270-279 [PMID: 28798922 DOI: 10.12998/wjcc.v5.i7.270] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
68 Baek WK, Kim YS, Kim JT, Yoon BN. Critical Illness Neuromyopathy Complicating Cardiac Surgery. Acute Crit Care 2018;33:51-6. [PMID: 31723861 DOI: 10.4266/acc.2016.00255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Kramer CL, Boon AJ, Harper CM, Goodman BP. Compound muscle action potential duration in critical illness neuromyopathy. Muscle Nerve 2018;57:395-400. [PMID: 28646510 DOI: 10.1002/mus.25732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
70 Witteveen E, Wieske L, van der Poll T, van der Schaaf M, van Schaik IN, Schultz MJ, Verhamme C, Horn J. Increased Early Systemic Inflammation in ICU-Acquired Weakness; A Prospective Observational Cohort Study*: . Critical Care Medicine 2017;45:972-9. [DOI: 10.1097/ccm.0000000000002408] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
71 Shepherd SJ, Newman R, Brett SJ, Griffith DM; Enhancing Rehabilitation After Critical Illness Programme Study Investigators. Pharmacological Therapy for the Prevention and Treatment of Weakness After Critical Illness: A Systematic Review. Crit Care Med 2016;44:1198-205. [PMID: 26958749 DOI: 10.1097/CCM.0000000000001652] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
72 Crespo V, James ML. Neuromuscular Disease in the Neurointensive Care Unit. Anesthesiol Clin 2016;34:601-19. [PMID: 27521200 DOI: 10.1016/j.anclin.2016.04.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
73 Mcmillan HJ, Dastgir J. Neuromuscular Complications in the Critically Ill Child. Pediatric Electromyography 2017. [DOI: 10.1007/978-3-319-61361-1_23] [Reference Citation Analysis]
74 Horn J, Hermans G. Intensive care unit-acquired weakness. Handb Clin Neurol 2017;141:531-43. [PMID: 28190434 DOI: 10.1016/B978-0-444-63599-0.00029-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
75 Arroyo J, Villate S, Bessolo E, Passaglia G, Ortiz GA, Galletti C. Utilidad de la electromiografía en el diagnóstico precoz de polineuropatía del paciente crítico con diagnóstico de sepsis. Neurología Argentina 2017;9:35-39. [DOI: 10.1016/j.neuarg.2016.11.003] [Reference Citation Analysis]
76 Marino PL. Bewegungsstörungen. Das ICU-Buch 2017. [DOI: 10.1016/b978-3-437-23162-9.00045-7] [Reference Citation Analysis]
77 Kollmar R. [Critical illness polyneuropathy and myopathy as neurological complications of sepsis]. Nervenarzt 2016;87:236-45. [PMID: 26842898 DOI: 10.1007/s00115-016-0071-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
78 Watanabe J, Ito E, Hatano M, Tohyama T, Okada Y, Takada Y. Recovery After Critical Illness Polyneuropathy in a Patient With Orthotopic Liver Transplantation: A Case Report. Transplantation Proceedings 2016;48:3207-9. [DOI: 10.1016/j.transproceed.2016.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Tadyanemhandu C, Manie S. Implementation of the physical function ICU test tool in a resource constrained intensive care unit to promote early mobilisation of critically ill patients- a feasibility study. Arch Physiother 2016;6:12. [PMID: 29340193 DOI: 10.1186/s40945-016-0026-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Cunningham C, Finlayson H. Critical illness polyneuromyopathy. CMAJ 2016;188:1104. [PMID: 27378461 DOI: 10.1503/cmaj.151272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Kramer C, Zoubaa S, Kretschmer A, Jordan D, Blobner M, Fink H. Denervation versus pre‐ and postsynaptic muscle immobilization: Effects On acetylcholine‐ and muscle‐specific tyrosine kinase receptors. Muscle Nerve 2016;55:101-8. [DOI: 10.1002/mus.25159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
82 Shepherd S, Batra A, Lerner DP. Review of Critical Illness Myopathy and Neuropathy. Neurohospitalist 2017;7:41-8. [PMID: 28042370 DOI: 10.1177/1941874416663279] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 11.1] [Reference Citation Analysis]
83 Pencle FK, Kureshi N, Benstead T, Christie SD. Critical illness myopathy in a cervical spine-injured patient. Spinal Cord Ser Cases 2016;2:16017. [PMID: 28053761 DOI: 10.1038/scsandc.2016.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Çankayalı İ, Boyacılar Ö, Demirağ K, Uyar M, Moral AR. Neuromuscular Dysfunction in Experimental Sepsis and Glutamine. Balkan Med J 2016;33:267-74. [PMID: 27308070 DOI: 10.5152/balkanmedj.2016.140483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
85 Jolley SE, Bunnell AE, Hough CL. ICU-Acquired Weakness. Chest. 2016;150:1129-1140. [PMID: 27063347 DOI: 10.1016/j.chest.2016.03.045] [Cited by in Crossref: 167] [Cited by in F6Publishing: 171] [Article Influence: 23.9] [Reference Citation Analysis]
86 Axer H, Grimm A, Pausch C, Teschner U, Zinke J, Eisenach S, Beck S, Guntinas-Lichius O, Brunkhorst FM, Witte OW. The impairment of small nerve fibers in severe sepsis and septic shock. Crit Care 2016;20:64. [PMID: 26984636 DOI: 10.1186/s13054-016-1241-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
87 Valentine SL, Nadkarni VM, Curley MA; Pediatric Acute Lung Injury Consensus Conference Group. Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2015;16:S73-85. [PMID: 26035367 DOI: 10.1097/PCC.0000000000000435] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
88 Médrinal C, Prieur G, Quesada AR, Gravier F, Bonnevie T. La neuro-myopathie de réanimation : physiopathologie et conséquences. Kinésithérapie, la Revue 2016;16:28-35. [DOI: 10.1016/j.kine.2015.10.005] [Reference Citation Analysis]
89 Hill NS. Acute Ventilatory Failure. Murray and Nadel's Textbook of Respiratory Medicine 2016. [DOI: 10.1016/b978-1-4557-3383-5.00099-3] [Reference Citation Analysis]
90 Wolpaw J, Cha S, Dorman T. Post-intensive Care Syndrome (PICS). Principles of Adult Surgical Critical Care 2016. [DOI: 10.1007/978-3-319-33341-0_45] [Reference Citation Analysis]
91 Benditt JO, Mccool FD. The Respiratory System and Neuromuscular Diseases. Murray and Nadel's Textbook of Respiratory Medicine 2016. [DOI: 10.1016/b978-1-4557-3383-5.00097-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Antypa E, Barbetakis N. Predictors of Prolonged Mechanical Ventilation in Lung Cancer: Use of Noninvasive Ventilation. Noninvasive Mechanical Ventilation and Difficult Weaning in Critical Care 2016. [DOI: 10.1007/978-3-319-04259-6_26] [Reference Citation Analysis]
93 Farhan H, Moreno-duarte I, Latronico N, Zafonte R, Eikermann M. Acquired Muscle Weakness in the Surgical Intensive Care Unit. Anesthesiology 2016;124:207-34. [DOI: 10.1097/aln.0000000000000874] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
94 Kowalczyk A, Jeleń A, Żebrowska M, Balcerczak E, Gorąca A. BQ123 Stimulates Skeletal Muscle Antioxidant Defense via Nrf2 Activation in LPS-Treated Rats. Oxid Med Cell Longev 2016;2016:2356853. [PMID: 26823945 DOI: 10.1155/2016/2356853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
95 Godleski M, Holden MS, Luby D, Weitzenkamp D, Boimbo S, Lindberg G. Clinical outcomes from a foam wedge splinting program for axillary contracture prevention in the intensive care unit. J Burn Care Res 2014;35:e379-86. [PMID: 24918948 DOI: 10.1097/BCR.0000000000000038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
96 Goodman BP, Boon AJ. Critical illness neuromyopathy. Evidence-Based Neurology: Management of Neurological Disorders 2015. [DOI: 10.1002/9781119067344.ch23] [Reference Citation Analysis]
97 Bagnato S, Minà C, Sant’angelo A, Boccagni C, Prestandrea C, Caronia A, Clemenza F, Galardi G. Occurrence of neuropathies in patients with severe heart failure before and after heart transplantation. Neurol Sci 2016;37:393-401. [DOI: 10.1007/s10072-015-2413-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
98 Prince D, Hsieh J. Early Rehabilitation in the Intensive Care Unit. Curr Phys Med Rehabil Rep 2015;3:214-221. [DOI: 10.1007/s40141-015-0094-1] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
99 Friedrich O, Reid MB, Van den Berghe G, Vanhorebeek I, Hermans G, Rich MM, Larsson L. The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev. 2015;95:1025-1109. [PMID: 26133937 DOI: 10.1152/physrev.00028.2014] [Cited by in Crossref: 191] [Cited by in F6Publishing: 205] [Article Influence: 23.9] [Reference Citation Analysis]
100 Hocker SE, Wijdicks EF. Neurologic complications of sepsis. Continuum (Minneap Minn) 2014;20:598-613. [PMID: 24893236 DOI: 10.1212/01.CON.0000450968.53581.ff] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
101 Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274. [PMID: 26242743 DOI: 10.1186/s13054-015-0993-7] [Cited by in Crossref: 297] [Cited by in F6Publishing: 320] [Article Influence: 37.1] [Reference Citation Analysis]
102 Creutzfeldt CJ, Hough CL. Get out of bed: immobility in the neurologic ICU. Crit Care Med 2015;43:926-7. [PMID: 25768363 DOI: 10.1097/CCM.0000000000000836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
103 Punsoni M, Drexler S, Palaia T, Stevenson M, Stecker MM. Acute anoxic changes in peripheral nerve: anatomic and physiologic correlations. Brain Behav 2015;5:e00347. [PMID: 26221572 DOI: 10.1002/brb3.347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
104 Solmaz V, Aksoy D, Yılmaz M, Eser E, Erbas O. Demonstration of ameliorative effect of lacosamide: in a rat model of sepsis-induced critical illness polyneuropathy. Neurol Res 2015;37:797-802. [PMID: 25916937 DOI: 10.1179/1743132815Y.0000000040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
105 Barnes BT, Confides AL, Rich MM, Dupont-Versteegden EE. Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy. J Muscle Res Cell Motil 2015;36:243-53. [PMID: 25740800 DOI: 10.1007/s10974-015-9410-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
106 Mehrholz J, Pohl M, Kugler J, Burridge J, Mückel S, Elsner B. Physical rehabilitation for critical illness myopathy and neuropathy. Cochrane Database Syst Rev 2015;:CD010942. [PMID: 25737049 DOI: 10.1002/14651858.CD010942.pub2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
107 Cabrera-serrano M, Fugate JE, Mandrekar J, Rabinstein AA. Impact of Hyperglycemia in the Outcome of Patients with Primary Neuromuscular Respiratory Failure. Neurocrit Care 2015;23:103-7. [DOI: 10.1007/s12028-015-0114-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Hartung H, Lehmann HC, Kieseier BC. Neuromuskuläre Erkrankungen bei Intensivpatienten. Die Intensivmedizin 2015. [DOI: 10.1007/978-3-642-54953-3_48] [Reference Citation Analysis]
109 Hartung H, Kieseier BC, Lehmann HC. Neuromuskuläre Erkrankungen bei Intensivpatienten. Die Intensivmedizin 2015. [DOI: 10.1007/978-3-642-54675-4_59-1] [Reference Citation Analysis]
110 Mars T, Mis K, Pirkmajer S, Katalinic M, Grubic Z. The Effects of Organophosphates in the Early Stages of Human Muscle Regeneration. Handbook of Toxicology of Chemical Warfare Agents 2015. [DOI: 10.1016/b978-0-12-800159-2.00051-8] [Reference Citation Analysis]
111 Sugiura Y, Kodama M, Hashizume T, Kaseda S, Nemoto E. Critical illness polyneuropathy caused after lung lobectomy for a patient with interstitial pneumonia: A case report. The Journal of the Japanese Association for Chest Surgery 2015;29:495-500. [DOI: 10.2995/jacsurg.29.495] [Reference Citation Analysis]
112 Koukourikos K, Tsaloglidou A, Kourkouta L. Muscle atrophy in intensive care unit patients. Acta Inform Med. 2014;22:406-410. [PMID: 25684851 DOI: 10.5455/aim.2014.22.406-410] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
113 Bolton CF. The Discovery of Critical Illness Polyneuropathy: A Memoir. Can j neurol sci 2010;37:431-8. [DOI: 10.1017/s031716710001043x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
114 Vargas-martínez F, Uvnäs-moberg K, Petersson M, Olausson HA, Jiménez-estrada I. Neuropeptides as neuroprotective agents: Oxytocin a forefront developmental player in the mammalian brain. Progress in Neurobiology 2014;123:37-78. [DOI: 10.1016/j.pneurobio.2014.10.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
115 Lemaire M, Preiser J. Activité physique et nutrition en réanimation. Nutrition Clinique et Métabolisme 2014;28:294-300. [DOI: 10.1016/j.nupar.2014.10.009] [Reference Citation Analysis]
116 Wieske L, Witteveen E, Verhamme C, Dettling-Ihnenfeldt DS, van der Schaaf M, Schultz MJ, van Schaik IN, Horn J. Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study. PLoS One 2014;9:e111259. [PMID: 25347675 DOI: 10.1371/journal.pone.0111259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
117 Ponfick M, Bösl K, Lüdemann-Podubecka J, Neumann G, Pohl M, Nowak DA, Gdynia HJ. [Intensive care unit acquired weakness. Pathogenesis, treatment, rehabilitation and outcome]. Nervenarzt 2014;85:195-204. [PMID: 24463649 DOI: 10.1007/s00115-013-3958-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
118 Zhou C, Wu L, Ni F, Ji W, Wu J, Zhang H. Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res. 2014;9:101-110. [PMID: 25206749 DOI: 10.4103/1673-5374.125337] [Cited by in Crossref: 91] [Cited by in F6Publishing: 102] [Article Influence: 10.1] [Reference Citation Analysis]
119 Ackermann KA, Bostock H, Brander L, Schröder R, Djafarzadeh S, Tuchscherer D, Jakob SM, Takala J, Z'Graggen WJ. Early changes of muscle membrane properties in porcine faecal peritonitis. Crit Care 2014;18:484. [PMID: 25145497 DOI: 10.1186/s13054-014-0484-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
120 Friedrich O, Yi B, Edwards JN, Reischl B, Wirth-Hücking A, Buttgereit A, Lang R, Weber C, Polyak F, Liu I, von Wegner F, Cully TR, Lee A, Most P, Völkers M. IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy? Am J Respir Cell Mol Biol 2014;50:1096-106. [PMID: 24400695 DOI: 10.1165/rcmb.2013-0059OC] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
121 Anthony DC, Lacomis D. Critical illness polyneuropathy. Peripheral nerve disorders 2014. [DOI: 10.1002/9781118618424.ch34] [Reference Citation Analysis]
122 Osias J, Manno E. Neuromuscular complications of critical illness. Crit Care Clin 2014;30:785-94. [PMID: 25257741 DOI: 10.1016/j.ccc.2014.06.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
123 Apostolakis E, Papakonstantinou NA, Baikoussis NG, Papadopoulos G. Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. J Anesth. 2015;29:112-121. [PMID: 24981564 DOI: 10.1007/s00540-014-1875-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
124 Latronico N, Nattino G, Guarneri B, Fagoni N, Amantini A, Bertolini G; GiVITI Study Investigators. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res 2014;3:127. [PMID: 25309729 DOI: 10.12688/f1000research.3933.3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
125 Latronico N, Nattino G, Guarneri B, Fagoni N, Amantini A, Bertolini G; GiVITI Study Investigators. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res 2014;3:127. [PMID: 25309729 DOI: 10.12688/f1000research.3933.3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 25] [Article Influence: 0.3] [Reference Citation Analysis]
126 Blessing MM, Reichard RR, Maleszewski JJ, Alexander MP. Myoglobinuria in Autopsy Pathology: Relevant and Potentially Unrecognized. Academic Forensic Pathology 2014;4:226-234. [DOI: 10.23907/2014.035] [Reference Citation Analysis]
127 Organization of rehabilitation services. Textbook of Neural Repair and Rehabilitation 2014. [DOI: 10.1017/cbo9780511995590.026] [Reference Citation Analysis]
128 Kukreti V, Shamim M, Khilnani P. Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy. Indian J Crit Care Med 2014;18:95-101. [PMID: 24678152 DOI: 10.4103/0972-5229.126079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
129 Mohamed A, Ryan MM. Neuromuscular complications of intensive care. Handb Clin Neurol 2013;113:1481-3. [PMID: 23622370 DOI: 10.1016/B978-0-444-59565-2.00017-4] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
130 Moss M, Yang M, Macht M, Sottile P, Gray L, McNulty M, Quan D. Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med 2014;40:683-90. [PMID: 24623137 DOI: 10.1007/s00134-014-3251-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
131 Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2014;:CD006832. [PMID: 24477672 DOI: 10.1002/14651858.CD006832.pub3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 79] [Article Influence: 4.1] [Reference Citation Analysis]
132 Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2014;CD006832. [PMID: 24477672 DOI: 10.1002/14651858.cd006832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
133 Mehrholz J, Pohl M, Kugler J, Burridge J, Mückel S, Mehrholz J. Physical rehabilitation for critical illness myopathy and neuropathy. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd010942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Wieske L, Witteveen E, Petzold A, Verhamme C, Schultz MJ, van Schaik IN, Horn J. Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study. Crit Care 2014;18:R18. [PMID: 24443841 DOI: 10.1186/cc13699] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
135 Lacomis D, El-dokla A. Acute Neuromuscular Weakness in the Intensive Care Unit. Neuromuscular Disorders in Clinical Practice 2014. [DOI: 10.1007/978-1-4614-6567-6_76] [Reference Citation Analysis]
136 Boesch RP, Sawnani H. Neuromuscular Respiratory Failure. Pediatric Critical Care Medicine 2014. [DOI: 10.1007/978-1-4471-6356-5_16] [Reference Citation Analysis]
137 Argov Z, Latronico N. Neuromuscular complications in intensive care patients. Handb Clin Neurol 2014;121:1673-85. [PMID: 24365440 DOI: 10.1016/B978-0-7020-4088-7.00108-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
138 Bertorini TE, Perez A. Neurologic complications of disorders of the adrenal glands. Handb Clin Neurol 2014;120:749-71. [PMID: 24365350 DOI: 10.1016/B978-0-7020-4087-0.00050-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
139 Morren JA, Manno EM. Neurologic Complications in Critically Ill Patients. Aminoff's Neurology and General Medicine 2014. [DOI: 10.1016/b978-0-12-407710-2.00056-4] [Reference Citation Analysis]
140 Dousse N, Vermeulen F, Brochard L. Comment, en pratique clinique, évaluer la force musculaire du patient de réanimation ? Réanimation 2014;23:109-115. [DOI: 10.1007/s13546-013-0827-z] [Reference Citation Analysis]
141 Angelopoulos E, Karatzanos E, Dimopoulos S, Mitsiou G, Stefanou C, Patsaki I, Kotanidou A, Routsi C, Petrikkos G, Nanas S. Acute microcirculatory effects of medium frequency versus high frequency neuromuscular electrical stimulation in critically ill patients - a pilot study. Ann Intensive Care. 2013;3:39. [PMID: 24355422 DOI: 10.1186/2110-5820-3-39] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
142 권기한, 민양기. Intensive Care Unit-acquired Weakness. jouranlofkoreanassociationofemgelectrodiagnosticmedicine 2013;15:64-72. [DOI: 10.18214/jkaem.2013.15.2.64] [Reference Citation Analysis]
143 Sagui E, Cordier PY, Nau A, Rogier C, Bregigeon M, Brosset C. Is critical illness polyneuropathy associated with decreased heart rate variability? Rev Neurol (Paris) 2014;170:32-6. [PMID: 24230479 DOI: 10.1016/j.neurol.2013.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
144 Koube I, Devroey M, Norrenberg M, Lemaire M, Bonnier F. Kinésithérapie chez le patient présentant une altération de l’état de conscience. Réanimation 2013;22:648-655. [DOI: 10.1007/s13546-013-0724-5] [Reference Citation Analysis]
145 Axer H, Grimm A, Porzelius C, Teschner U, Schumacher U, Witte OW, Brunkhorst FM. Impairment of small somatic and autonomic nerve fibres in intensive care unit patients with severe sepsis and critical illness polyneuropathy--a single center controlled observational study. BMC Neurol 2013;13:159. [PMID: 24176121 DOI: 10.1186/1471-2377-13-159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
146 Grimm A, Brunkhorst FM, Axer H. Sepsis-induzierte CIP und CIM. NeuroTransmitter 2013;24:36-43. [DOI: 10.1007/s15016-013-0436-0] [Reference Citation Analysis]
147 Grimm A, Teschner U, Porzelius C, Ludewig K, Zielske J, Witte OW, Brunkhorst FM, Axer H. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care 2013;17:R227. [PMID: 24499688 DOI: 10.1186/cc13050] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 8.2] [Reference Citation Analysis]
148 Karnatovskaia LV, Festic E. Sepsis: a review for the neurohospitalist. Neurohospitalist 2012;2:144-53. [PMID: 23983879 DOI: 10.1177/1941874412453338] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
149 Erbaş O, Yeniel AÖ, Akdemir A, Ergenoğlu AM, Yilmaz M, Taskiran D, Peker G. The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence. J Invest Surg 2013;26:312-8. [PMID: 23957613 DOI: 10.3109/08941939.2013.797056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
150 Gueret G, Guillouet M, Vermeersch V, Guillard E, Talarmin H, Nguyen BV, Rannou F, Giroux-Metges MA, Pennec JP, Ozier Y. [ICU acquired neuromyopathy]. Ann Fr Anesth Reanim 2013;32:580-91. [PMID: 23958176 DOI: 10.1016/j.annfar.2013.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Kress JP. Sedation and mobility: changing the paradigm. Crit Care Clin 2013;29:67-75. [PMID: 23182528 DOI: 10.1016/j.ccc.2012.10.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
152 Axer H, Zinke J, Axer M, Grimm A. Elektrophysiologische Diagnostik der Critical Illness Polyneuropathie und Critical Illness Myopathie. Das Neurophysiologie-Labor 2013;35:18-33. [DOI: 10.1016/j.neulab.2013.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
153 Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve 2013;47:452-63. [PMID: 23386582 DOI: 10.1002/mus.23615] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
154 Roeseler J, Sottiaux T, Lemiale V, Lesny M, Beduneau G, Bialais E, Bradaï N, Castelain V, Dinomais M, Dousse N, Fontaine L, Guérin C, Hickmann C, Jougleux M, Kouki S, Leboucher F, Lemaire M, Nassaj A, Nunes J, Robain G, Thiollière F, Thivellier A, Wittebole X, Osman D, Bretonnière C, Boulain T, Chaoui K, Cravoisy A, Da Silva D, Djibré M, Fieux F, Hurel D, Lemiale V, Lesieur O, Lesny M, Milesi C, Misset B, Quenot J-, Soufir L, Vong L, Titomanlio L. Prise en charge de la mobilisation précoce en réanimation, chez l’adulte et l’enfant (électrostimulation incluse). Réanimation 2013;22:207-18. [DOI: 10.1007/s13546-013-0658-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
155 Dos Santos CC, Batt J. ICU-acquired weakness: mechanisms of disability. Curr Opin Crit Care 2012;18:509-17. [PMID: 22918258 DOI: 10.1097/MCC.0b013e328357cb5e] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
156 Mauermann ML, Burns TM. Peripheral Nerve Disorders in Systemic Disease. Neurological Disorders due to Systemic Disease 2013. [DOI: 10.1002/9781118414019.ch11] [Reference Citation Analysis]
157 Nardelli P, Khan J, Powers R, Cope TC, Rich MM. Reduced motoneuron excitability in a rat model of sepsis. J Neurophysiol 2013;109:1775-81. [PMID: 23303860 DOI: 10.1152/jn.00936.2012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
158 Farivar BS, Eiref SD, Leitman IM. Strategies to prevent sepsis-induced intensive care unit-acquired weakness: are there any options? Commentary on "Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with surgically induced sepsis". J Surg Res 2013;185:e39-42. [PMID: 23295195 DOI: 10.1016/j.jss.2012.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
159 Shindo K, Sugiyama K, Nishijima K, Furusawa Y, Kondo T, Izumi S. Rehabilitation of four patients with critical illness polyneuropathy following living-donor liver transplantation. Jpn J Compr Rehabil Sci 2013;4:67-72. [DOI: 10.11336/jjcrs.4.67] [Reference Citation Analysis]
160 Preston DC, Shapiro BE. Approach to Electrodiagnostic Studies in the Intensive Care Unit. Electromyography and Neuromuscular Disorders 2013. [DOI: 10.1016/b978-1-4557-2672-1.00037-4] [Reference Citation Analysis]
161 Wieske L, Schultz MJ, Horn J. Diagnostic Approach to ICU-acquired Weakness: Present and Future. Annual Update in Intensive Care and Emergency Medicine 2013 2013. [DOI: 10.1007/978-3-642-35109-9_64] [Reference Citation Analysis]
162 Crone C, Krarup C. Neurophysiological approach to disorders of peripheral nerve. Handb Clin Neurol 2013;115:81-114. [PMID: 23931776 DOI: 10.1016/B978-0-444-52902-2.00006-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
163 Erbaş O, Ergenoglu AM, Akdemir A, Yeniel AÖ, Taskiran D. Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis. J Surg Res 2013;183:313-20. [PMID: 23312812 DOI: 10.1016/j.jss.2012.11.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
164 Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med. 2013;187:238-246. [PMID: 23204256 DOI: 10.1164/rccm.201205-0954so] [Cited by in Crossref: 152] [Cited by in F6Publishing: 160] [Article Influence: 13.8] [Reference Citation Analysis]
165 Lacomis D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis 2011;12:197-218. [PMID: 22361518 DOI: 10.1097/CND.0b013e3181b5e14d] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
166 Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med. 2007;18:90-100. [PMID: 17338959 DOI: 10.1016/j.ejim.2006.09.020] [Cited by in Crossref: 165] [Cited by in F6Publishing: 179] [Article Influence: 15.0] [Reference Citation Analysis]
167 Robinson-Papp J. Infectious neuropathies. Continuum (Minneap Minn) 2012;18:126-38. [PMID: 22810073 DOI: 10.1212/01.CON.0000411566.26462.04] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
168 Semmler A, Okulla T, Kaiser M, Seifert B, Heneka MT. Long-term neuromuscular sequelae of critical illness. J Neurol 2013;260:151-7. [PMID: 22820684 DOI: 10.1007/s00415-012-6605-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
169 Hirabayashi K, Shiohara M, Suzuki T, Saito S, Tanaka M, Yanagisawa R, Tsuruta G, Fukuyama T, Hidaka Y, Nakazawa Y, Shimizu T, Sakashita K, Koike K. Critical illness polyneuropathy and myopathy caused by Bacillus cereus sepsis in acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2012;34:e110-3. [PMID: 22246161 DOI: 10.1097/MPH.0b013e318234620b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
170 Manno Manno EM. Neurological Complications of Medical Illness: Critical Illness Neuropathy and Myopathy. Emergency Management in Neurocritical Care 2012. [DOI: 10.1002/9781118297162.ch20] [Reference Citation Analysis]
171 Jackson JC, Ely EW, Morey MC, Anderson VM, Denne LB, Clune J, Siebert CS, Archer KR, Torres R, Janz D, Schiro E, Jones J, Shintani AK, Levine B, Pun BT, Thompson J, Brummel NE, Hoenig H. Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med 2012;40:1088-97. [PMID: 22080631 DOI: 10.1097/CCM.0b013e3182373115] [Cited by in Crossref: 190] [Cited by in F6Publishing: 199] [Article Influence: 17.3] [Reference Citation Analysis]
172 Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K, Vasileiadis I, Papadopoulos E, Mitsiou G, Tsimpouki D, Routsi C, Nanas S. Electrical muscle stimulation: an effective form of exercise and early mobilization to preserve muscle strength in critically ill patients. Crit Care Res Pract 2012;2012:432752. [PMID: 22545212 DOI: 10.1155/2012/432752] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
173 Judemann K, Lunz D, Zausig YA, Graf BM, Zink W. [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy]. Anaesthesist 2011;60:887-901. [PMID: 22006117 DOI: 10.1007/s00101-011-1951-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
174 Lunardi N, Bryant M, Smith K, Lowson S. Early Mobilization in Critically Ill Patients. ICU Director 2012;3:17-20. [DOI: 10.1177/1944451611435275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
175 Nordon-Craft A, Moss M, Quan D, Schenkman M. Intensive care unit-acquired weakness: implications for physical therapist management. Phys Ther 2012;92:1494-506. [PMID: 22282769 DOI: 10.2522/ptj.20110117] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
176 Wijdicks EFM. First Descriptions of Clinical Syndromes. Famous First Papers for the Neurointensivist 2012. [DOI: 10.1007/978-1-4614-3182-4_4] [Reference Citation Analysis]
177 Bagnato S, Boccagni C, Sant'angelo A, Prestandrea C, Romano MC, Galardi G. Neuromuscular involvement in vegetative and minimally conscious states following acute brain injury. Journal of the Peripheral Nervous System 2011;16:315-21. [DOI: 10.1111/j.1529-8027.2011.00363.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
178 Matsuda N, Kobayashi S, Tanji Y, Hasegawa A, Tase C, Ugawa Y. Widespread muscle involvement in critical illness myopathy revealed by MRI. Muscle Nerve 2011;44:842-4. [PMID: 22006705 DOI: 10.1002/mus.22218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
179 Schweickert WD, Kress JP. Implementing Early Mobilization Interventions in Mechanically Ventilated Patients in the ICU. Chest 2011;140:1612-7. [DOI: 10.1378/chest.10-2829] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 7.6] [Reference Citation Analysis]
180 Cucurachi L, Sperber SA. Meningococcemia presenting as acute painful mononeuritis multiplex. Clin Neurol Neurosurg 2012;114:284-6. [PMID: 22100105 DOI: 10.1016/j.clineuro.2011.10.031] [Reference Citation Analysis]
181 Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011;10:931-41. [PMID: 21939902 DOI: 10.1016/S1474-4422(11)70178-8] [Cited by in Crossref: 390] [Cited by in F6Publishing: 418] [Article Influence: 32.5] [Reference Citation Analysis]
182 Anastasopoulos D, Kefaliakos A, Michalopoulos A. Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy? Crit Care 2011;15:R247. [PMID: 22018206 DOI: 10.1186/cc10505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
183 . Neurointensive care. Core Topics in Neuroanaesthesia and Neurointensive Care 2011. [DOI: 10.1017/cbo9780511977558.019] [Reference Citation Analysis]
184 Hirsch N, Howard R. Neuromuscular disorders. Core Topics in Neuroanaesthesia and Neurointensive Care 2011. [DOI: 10.1017/cbo9780511977558.027] [Reference Citation Analysis]
185 Perreault S, Birca A, Piper D, Nadeau A, Gauvin F, Vanasse M. Transient Creatine Phosphokinase Elevations in Children: A Single-Center Experience. The Journal of Pediatrics 2011;159:682-5. [DOI: 10.1016/j.jpeds.2011.03.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
186 Baum P, Bercker S, Villmann T, Classen J, Hermann W. [Critical illness myopathy and neuropathy (CRIMYN). Electroneurographic classification]. Nervenarzt 2011;82:468-74. [PMID: 21340635 DOI: 10.1007/s00115-010-3094-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
187 Maes K, Testelmans D, Thomas D, Decramer M, Gayan-ramirez G. High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function. Intensive Care Med 2011;37. [DOI: 10.1007/s00134-011-2337-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
188 Wu CT, Huang JL, Lin JJ, Hsia SH. Factors associated with nontraumatic rhabdomyolysis and acute renal failure of children in Taiwan population. Pediatr Emerg Care 2009;25:657-60. [PMID: 21465694 DOI: 10.1097/pec.0b013e3181bec7b4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
189 Gurjar M, Azim A, Baronia AK, Poddar B. Facial nerve involvement in critical illness polyneuropathy. Indian J Anaesth 2010;54:472-4. [PMID: 21189890 DOI: 10.4103/0019-5049.71038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
190 Bird SJ. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol 2007;9:85-92. [PMID: 17298769 DOI: 10.1007/s11940-007-0034-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
191 Tzanis G, Vasileiadis I, Zervakis D, Karatzanos E, Dimopoulos S, Pitsolis T, Tripodaki E, Gerovasili V, Routsi C, Nanas S. Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness. BMC Anesthesiol 2011;11:14. [PMID: 21703029 DOI: 10.1186/1471-2253-11-14] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
192 Weber-carstens S, Goldmann A. Einsatz von Muskelrelaxanzien im Frühstadium des akuten Lungenversagens. Intensivmed 2011;48:226-228. [DOI: 10.1007/s00390-011-0280-z] [Reference Citation Analysis]
193 Burkhead LM. Swallowing Evaluation and Ventilator Dependency—Considerations and Contemporary Approaches. Perspect Swal Swal Dis (Dysph) 2011;20:18-22. [DOI: 10.1044/sasd20.1.18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
194 Hough CL, Lieu BK, Caldwell ES. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care. 2011;15:R43. [PMID: 21276225 DOI: 10.1186/cc10005] [Cited by in Crossref: 131] [Cited by in F6Publishing: 141] [Article Influence: 10.9] [Reference Citation Analysis]
195 Chawla J, Gruener G. Management of critical illness polyneuropathy and myopathy. Neurol Clin 2010;28:961-77. [PMID: 20816273 DOI: 10.1016/j.ncl.2010.03.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
196 Crystal HA, Torrico PJ, Gandhi S, Maccabee PJ. Effects of Aging on the Nervous System. Principles and Practice of Geriatric Surgery 2011. [DOI: 10.1007/978-1-4419-6999-6_85] [Reference Citation Analysis]
197 Hartung H, Kieseier BC, Lehmann HC. Neuromuskuläre Erkrankungen bei Intensivpatienten. Die Intensivmedizin 2011. [DOI: 10.1007/978-3-642-16929-8_56] [Reference Citation Analysis]
198 Z'Graggen WJ, Brander L, Tuchscherer D, Scheidegger O, Takala J, Bostock H. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol 2011;122:834-41. [PMID: 21044861 DOI: 10.1016/j.clinph.2010.09.024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
199 Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, Spies CD, Spuler S, Keh D. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 2010;14:R119. [PMID: 20565863 DOI: 10.1186/cc9074] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
200 Keh D, Weber-Carstens S, Ahlers O. Adjunctive therapies in severe sepsis and septic shock: current place of steroids. Curr Infect Dis Rep 2008;10:354-61. [PMID: 18687198 DOI: 10.1007/s11908-008-0058-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
201 Al-lozi M, Pestronk A. Critical Illness Myopathy. International Neurology 2010. [DOI: 10.1002/9781444317008.ch117] [Reference Citation Analysis]
202 Frick CG, Helming M, Martyn JA, Blobner M, Fink H. Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. Crit Care Med 2010;38:922-7. [PMID: 20009758 DOI: 10.1097/CCM.0b013e3181c31297] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
203 Zink W, Kollmar R, Schwab S. Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol 2009;5:372-9. [PMID: 19578344 DOI: 10.1038/nrneurol.2009.75] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
204 Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, Ali NA, Sharshar T. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37:S299-308. [PMID: 20046114 DOI: 10.1097/CCM.0b013e3181b6ef67] [Cited by in Crossref: 340] [Cited by in F6Publishing: 372] [Article Influence: 26.2] [Reference Citation Analysis]
205 Kucik CJ, Bittner EA, Martyn JA. Is There a Polymyopathy or Polyneuropathy of Critical Illness? What Is It and How Is It Diagnosed and Managed? How Does It Affect Outcome? Evidence-Based Practice of Critical Care 2010. [DOI: 10.1016/b978-1-4160-5476-4.00061-4] [Reference Citation Analysis]
206 Hill NS, Schmidt GA. Acute Ventilatory Failure. Murray and Nadel's Textbook of Respiratory Medicine 2010. [DOI: 10.1016/b978-1-4160-4710-0.00092-4] [Reference Citation Analysis]
207 Benditt JO, Mccool FD. The Respiratory System and Neuromuscular Diseases. Murray and Nadel's Textbook of Respiratory Medicine 2010. [DOI: 10.1016/b978-1-4160-4710-0.00087-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
208 Osuchowski MF, Teener J, Remick D. Noninvasive model of sciatic nerve conduction in healthy and septic mice: reliability and normative data. Muscle Nerve 2009;40:610-6. [PMID: 19618431 DOI: 10.1002/mus.21284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
209 Friedrich O, Hund E, von Wegner F. Enhanced muscle shortening and impaired Ca2+ channel function in an acute septic myopathy model. J Neurol 2010;257:546-55. [DOI: 10.1007/s00415-009-5362-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
210 Goodman BP, Harper CM, Boon AJ. Prolonged compound muscle action potential duration in critical illness myopathy: Prolonged CMAP in CIM. Muscle Nerve 2009;40:1040-2. [DOI: 10.1002/mus.21445] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
211 Hermans G, Vanhorebeek I, Derde S, Van den Berghe G. Metabolic aspects of critical illness polyneuromyopathy: . Critical Care Medicine 2009;37:S391-7. [DOI: 10.1097/ccm.0b013e3181b6f01a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
212 Brunello A, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM. Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Med 2010;36:66-74. [DOI: 10.1007/s00134-009-1645-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
213 Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, Wernecke KD, Deja M. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009;37:2632-7. [PMID: 19623045 DOI: 10.1097/CCM.0b013e3181a92f28] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 5.1] [Reference Citation Analysis]
214 Kruse AL, Dannemann C, Grätz KW. Bilateral myositis ossificans of the masseter muscle after chemoradiotherapy and critical illness neuropathy--report of a rare entity and review of literature. Head Neck Oncol 2009;1:30. [PMID: 19674466 DOI: 10.1186/1758-3284-1-30] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
215 Rajabally Y, Ramlackhansingh A, Fraser M, Abbott R. Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection. Neurophysiologie Clinique/Clinical Neurophysiology 2009;39:135-8. [DOI: 10.1016/j.neucli.2009.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
216 Novak KR, Nardelli P, Cope TC, Filatov G, Glass JD, Khan J, Rich MM. Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 2009;119:1150-8. [PMID: 19425168 DOI: 10.1172/jci36570] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 5.7] [Reference Citation Analysis]
217 Harikumar G, Moxham J, Greenough A, Rafferty GF. Measurement of maximal inspiratory pressure in ventilated children. Pediatr Pulmonol 2008;43:1085-91. [PMID: 18846557 DOI: 10.1002/ppul.20905] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
218 Amaya Villar R, Garnacho-montero J, Rincón Ferrari M. Patología neuromuscular en cuidados intensivos. Medicina Intensiva 2009;33:123-33. [DOI: 10.1016/s0210-5691(09)70945-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
219 Ahrens J, Leuwer M, Foadi N, Haeseler G. The role of endotoxin in critical illness myopathy and polyneuropathy. J Neurol 2009;256:1354-1354. [DOI: 10.1007/s00415-009-5099-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Dyer B, Barrow A, Coakley J. Critical care-associated weakness. Anaesthesia & Intensive Care Medicine 2009;10:141-143. [DOI: 10.1016/j.mpaic.2009.01.005] [Reference Citation Analysis]
221 Hermans G, Schrooten M, Van Damme P, Berends N, Bouckaert B, De Vooght W, Robberecht W, Van den Berghe G. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care 2009;13:R5. [PMID: 19166623 DOI: 10.1186/cc7694] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
222 Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2009;:CD006832. [PMID: 19160304 DOI: 10.1002/14651858.CD006832.pub2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 51] [Article Influence: 1.9] [Reference Citation Analysis]
223 Rubin M, Klein A. The Differential Diagnosis of Inflammatory Myopathy. The Inflammatory Myopathies 2009. [DOI: 10.1007/978-1-60327-827-0_14] [Reference Citation Analysis]
224 Mars T, Mis K, Pirkmajer S, Grubic Z. The Effects of Organophosphates in the Early Stages of Human Muscle Regeneration. Handbook of Toxicology of Chemical Warfare Agents 2009. [DOI: 10.1016/b978-012374484-5.00045-6] [Reference Citation Analysis]
225 Mirski MA, Stevens RD, Geocadin RG, Carhuapoma J, Ziai WC, Hanley DF, Nyquist PA, Naval NS, Koenig M. Critical Care Neurology. Atlas of Clinical Neurology 2009. [DOI: 10.1007/978-1-57340-359-7_4] [Reference Citation Analysis]
226 Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: Critical illness polyneuropathy and myopathy. Crit Care. 2008;12:238. [PMID: 19040777 DOI: 10.1186/cc7100] [Cited by in Crossref: 187] [Cited by in F6Publishing: 200] [Article Influence: 12.5] [Reference Citation Analysis]
227 Shehu I, Peli E. Phrenic nerve stimulation. Eur J Anaesthesiol Suppl 2008;42:186-91. [PMID: 18289440 DOI: 10.1017/S0265021507003377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
228 Friedrich O. Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system. Eur J Anaesthesiol Suppl 2008;42:73-82. [PMID: 18289421 DOI: 10.1017/S0265021507003262] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
229 Bolton CF. The discovery of critical illness polyneuropathy. Eur J Anaesthesiol Suppl 2008;42:66-7. [PMID: 18289419 DOI: 10.1017/S0265021508003530] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
230 Nanas S, Kritikos K, Angelopoulos E, Siafaka A, Tsikriki S, Poriazi M, Kanaloupiti D, Kontogeorgi M, Pratikaki M, Zervakis D, Routsi C, Roussos C. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 2008;118:175-81. [PMID: 18355395 DOI: 10.1111/j.1600-0404.2008.00996.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 5.9] [Reference Citation Analysis]
231 Brown D, Cuccurullo S, Lee J, Petagna A, Strax T. Electrodiagnostic Medicine Skills Competency in Physical Medicine and Rehabilitation Residents: A Method for Development and Assessment. American Journal of Physical Medicine & Rehabilitation 2008;87:654-65. [DOI: 10.1097/phm.0b013e31816de0f2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
232 Mullassery D, Curran A, Losty PD. Critical illness polyneuropathy following childhood appendicitis. Pediatr Surg Int 2008;24:1067-8. [PMID: 18665371 DOI: 10.1007/s00383-008-2198-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 Zagli G, Tarantini F, Bonizzoli M, Di Filippo A, Peris A, De Gaudio AR, Geppetti P. Altered pharmacology in the Intensive Care Unit patient. Fundam Clin Pharmacol. 2008;22:493-501. [PMID: 18684127 DOI: 10.1111/j.1472-8206.2008.00623.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
234 Young GB. Critical illness myopathy: deeper insights. Crit Care Med 2008;36:1977. [PMID: 18520663 DOI: 10.1097/CCM.0b013e318176aa87] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
235 Fink H, Helming M, Unterbuchner C, Lenz A, Neff F, Martyn JA, Blobner M. Systemic inflammatory response syndrome increases immobility-induced neuromuscular weakness. Crit Care Med 2008;36:910-6. [PMID: 18431280 DOI: 10.1097/CCM.0B013E3181659669] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
236 Schmutzhard E, Pfausler B. It's not only biochemistry: a possible pathogenetic role of immobilization/immobility in critical illness polyneuromyopathy. Crit Care Med 2008;36:1021-2. [PMID: 18431314 DOI: 10.1097/CCM.0B013E318164ED9D] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Young GB. Critical illness myopathy: a direct role for endotoxin. Crit Care Med 2008;36:1381-2. [PMID: 18379281 DOI: 10.1097/CCM.0b013e31816a10c7] [Reference Citation Analysis]
238 Haeseler G, Foadi N, Wiegand E, Ahrens J, Krampfl K, Dengler R, Leuwer M. Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials. Crit Care Med 2008;36:1239-47. [PMID: 18379251 DOI: 10.1097/CCM.0b013e31816a02cf] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
239 Fernández-Torre JL, Teja JL, Castellanos A, Figols J, Obeso T, Arteaga R. Spinal muscular atrophy type I mimicking critical illness neuropathy in a paediatric intensive care neonate: electrophysiological features. Brain Dev 2008;30:599-602. [PMID: 18384992 DOI: 10.1016/j.braindev.2008.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
240 Pustavoitau A, Stevens RD. Mechanisms of neurologic failure in critical illness. Crit Care Clin. 2008;24:1-24, vii. [PMID: 18241776 DOI: 10.1016/j.ccc.2007.11.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
241 Khan J, Harrison TB, Rich MM. Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin 2008;24:165-77, x. [PMID: 18241784 DOI: 10.1016/j.ccc.2007.10.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
242 Hough CL, Needham DM. The role of future longitudinal studies in ICU survivors: understanding determinants and pathophysiology of weakness and neuromuscular dysfunction. Curr Opin Crit Care 2007;13:489-96. [PMID: 17762224 DOI: 10.1097/MCC.0b013e3282efea3a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
243 Rivas S, Douds GL, Ostdahl RH, Harbaugh KS. Fulminant Guillain–Barré syndrome after closed head injury: a potentially reversible cause of an ominous examination: Case report. JNS 2008;108:595-600. [DOI: 10.3171/jns/2008/108/3/0595] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
244 Mohammadi B, Schedel I, Graf K, Teiwes A, Hecker H, Haameijer B, Scheinichen D, Piepenbrock S, Dengler R, Bufler J. Role of endotoxin in the pathogenesis of critical illness polyneuropathy. J Neurol 2008;255:265-72. [PMID: 18283402 DOI: 10.1007/s00415-008-0722-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
245 Goodman BP, Boon AJ. Critical Illness Neuromyopathy. Physical Medicine and Rehabilitation Clinics of North America 2008;19:97-110. [DOI: 10.1016/j.pmr.2007.10.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
246 Williams TA, Leslie GD. Beyond the walls: A review of ICU clinics and their impact on patient outcomes after leaving hospital. Australian Critical Care 2008;21:6-17. [DOI: 10.1016/j.aucc.2007.11.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
247 Khan J, Harrison T. CENTRAL AND PERIPHERAL NEUROLOGIC MANIFESTATIONS OF CRITICAL MEDICAL ILLNESS. CONTINUUM: Lifelong Learning in Neurology 2008;14:74-93. [DOI: 10.1212/01.con.0000299987.78952.3d] [Reference Citation Analysis]
248 Hartung H, Kieseier B, Schroeter M. Neuromuskuläre Störungen beim Intensivpatienten, Critical-illness-Neuropathie und andere neurologische Störungen. Die Intensivmedizin 2008. [DOI: 10.1007/978-3-540-72296-0_55] [Reference Citation Analysis]
249 Bertorini TE. A Myasthenic Woman with Persistent Weakness. Neuromuscular Case Studies 2008. [DOI: 10.1016/b978-0-7506-7332-7.50051-9] [Reference Citation Analysis]
250 Hotson JR. Neurological Complications of Cardiac Surgery. Neurology and General Medicine 2008. [DOI: 10.1016/b978-044306707-5.50006-7] [Reference Citation Analysis]
251 Fredriksson K, Rooyackers O. Mitochondrial function in sepsis: respiratory versus leg muscle. Crit Care Med 2007;35:S449-53. [PMID: 17713392 DOI: 10.1097/01.CCM.0000278048.00896.4B] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
252 Bolton C, Thompson J, Bernardi L, Voll C, Young B. The cardiac R-R variation and sympathetic skin response in the intensive care unit. Can J Neurol Sci 2007;34:313-5. [PMID: 17803028 DOI: 10.1017/s0317167100006739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
253 Frick CG, Fink H, Gordan ML, Eckel B, Martyn JA, Blobner M. Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers. Intensive Care Med 2008;34:561-7. [PMID: 17952407 DOI: 10.1007/s00134-007-0852-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
254 Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, Hinson G, Mayer A, Morton N, Ralph T, Wolf A; United Kingdom Paediatric Intensive Care Society Sedation, Analgesia and Neuromuscular Blockade Working Group. Consensus guidelines for sustained neuromuscular blockade in critically ill children. Paediatr Anaesth 2007;17:881-7. [PMID: 17683408 DOI: 10.1111/j.1460-9592.2007.02313.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
255 Crone C, Krarup C. Diagnosis of acute neuropathies. J Neurol 2007;254:1151-69. [DOI: 10.1007/s00415-007-0532-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
256 Campellone JV. Respiratory muscle weakness in patients with critical illness neuromyopathies: A practical assessment*: . Critical Care Medicine 2007;35:2205-6. [DOI: 10.1097/01.ccm.0000281455.67799.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
257 Friedrich O, Hund E. [Critical illness myopathy in intensive care patients. Pathogenetic concepts and clinical management]. Anaesthesist 2006;55:1271-80. [PMID: 17165098 DOI: 10.1007/s00101-006-1100-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
258 Stevens RD, Dowdy DW, Michaels RK, Mendez-tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007;33:1876-91. [DOI: 10.1007/s00134-007-0772-2] [Cited by in Crossref: 409] [Cited by in F6Publishing: 431] [Article Influence: 25.6] [Reference Citation Analysis]
259 Bolton CF, Young GB. Managing the nervous system effects of sepsis. Chest 2007;131:1273-4. [PMID: 17494774 DOI: 10.1378/chest.07-0367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
260 Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E, Andreoletti S, Bera P, Luciani D, Nardella A, Vittorielli E, Simini B, Candiani A. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care 2007;11:R11. [PMID: 17254336 DOI: 10.1186/cc5671] [Cited by in Crossref: 103] [Cited by in F6Publishing: 113] [Article Influence: 6.4] [Reference Citation Analysis]
261 Schweickert WD, Hall J. ICU-Acquired Weakness. Chest 2007;131:1541-9. [DOI: 10.1378/chest.06-2065] [Cited by in Crossref: 230] [Cited by in F6Publishing: 243] [Article Influence: 14.4] [Reference Citation Analysis]
262 Williams S, Horrocks IA, Ouvrier RA, Gillis J, Ryan MM. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review. Pediatr Crit Care Med 2007;8:18-22. [PMID: 17251877 DOI: 10.1097/01.pcc.0000256623.01254.40] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
263 Echaniz-Laguna A. [Neuromuscular complications in transplant recipients]. Rev Neurol (Paris) 2007;163:275-85. [PMID: 17404516 DOI: 10.1016/s0035-3787(07)90401-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
264 Rannou F, Pennec J, Rossignol B, Morel J, Dorange G, Arvieux C, Gioux M, Giroux-metges M. Effects of chronic sepsis on rat motor units: Experimental study of critical illness polyneuromyopathy. Experimental Neurology 2007;204:741-7. [DOI: 10.1016/j.expneurol.2007.01.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
265 Orrell RW. Endocrine myopathies. Myopathies. Elsevier; 2007. pp. 343-55. [DOI: 10.1016/s0072-9752(07)86017-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
266 Linos K, Foot C, Ziegenfuss M, David Freeman W, Meng Tan K. Critical illness weakness: Common questions. Current Anaesthesia & Critical Care 2007;18:252-60. [DOI: 10.1016/j.cacc.2007.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
267 Lee Hough C. Neuromuscular Sequelae in Survivors of Acute Lung Injury. Clinics in Chest Medicine 2006;27:691-703. [DOI: 10.1016/j.ccm.2006.07.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
268 Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007;175:480-9. [PMID: 17138955 DOI: 10.1164/rccm.200605-665OC] [Cited by in Crossref: 240] [Cited by in F6Publishing: 255] [Article Influence: 14.1] [Reference Citation Analysis]
269 Maramattom BV, Wijdicks EF. Acute neuromuscular weakness in the intensive care unit. Crit Care Med 2006;34:2835-41. [PMID: 16932235 DOI: 10.1097/01.CCM.0000239436.63452.81] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
270 Mehta R, Fisher LE Jr, Segeleon JE, Pearson-Shaver AL, Wheeler DS. Acute rhabdomyolysis complicating status asthmaticus in children: case series and review. Pediatr Emerg Care 2006;22:587-91. [PMID: 16912630 DOI: 10.1097/01.pec.0000230711.81646.7a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
271 Visser LH. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol 2006;13:1203-12. [PMID: 17038033 DOI: 10.1111/j.1468-1331.2006.01498.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.2] [Reference Citation Analysis]
272 Murray MJ, Brull SJ, Bolton CF. Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anesth 2006;53:1148-56. [DOI: 10.1007/bf03022883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
273 Griffiths RD, Bongers T, Mcardle A. Skeletal Muscle. Update in Intensive Care and Emergency Medicine. [DOI: 10.1007/3-540-30328-6_31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
274 Teener JW, Rich MM. Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil 2006;27:291-6. [DOI: 10.1007/s10974-006-9074-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
275 Maramattom BV, Wijdicks EF. Neuromuscular disorders in medical and surgical ICUs: case studies in critical care neurology. Neurol Clin 2006;24:371-83. [PMID: 16684638 DOI: 10.1016/j.ncl.2006.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
276 Prelovsek O, Mars T, Jevsek M, Podbregar M, Grubic Z. High dexamethasone concentration prevents stimulatory effects of TNF-alpha and LPS on IL-6 secretion from the precursors of human muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2006;291:R1651-6. [PMID: 16857895 DOI: 10.1152/ajpregu.00020.2006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
277 Friedrich O. Critical illness myopathy: what is happening? Current Opinion in Clinical Nutrition & Metabolic Care 2006;9:403-9. [DOI: 10.1097/01.mco.0000232900.59168.a0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
278 医学と医療の最前線  Critical illness polyneuropathyの診断と治療. J Jpn Soc Intern Med 2006;95:158-164. [DOI: 10.2169/naika.95.158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]